Q1 2018 Holdings
Filed 2018-05-14 | 51 holdings | $35.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $16.3M | 6,812,764 | 45.3% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $15.7M | 911,707 | 43.8% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $3.3M | 720,529 | 9.2% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $49.3K | 1,656,720 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $44.3K | 1,443,948 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $43.6K | 1,581,416 | 0.1% |
| Horizon Pharma PLC | SHS | G4617B105 | $36.4K | 2,564,175 | 0.1% |
| Corium Intl Inc | COM | 21887L107 | $35.8K | 3,119,645 | 0.1% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $27.1K | 1,135,203 | 0.1% |
| Retrophin Inc | COM | 761299106 | $26.3K | 1,178,226 | 0.1% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $24.7K | 2,793,752 | 0.1% |
| Recro Pharma Inc | COM | 75629F109 | $24.6K | 2,236,025 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $21.5K | 537,380 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $19.7K | 175,030 | 0.1% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $19.1K | 2,624,663 | 0.1% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $18.9K | 4,294,426 | 0.1% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $16.5K | 298,424 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $15.4K | 912,987 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $13.5K | 258,292 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $12.1K | 598,800 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $10.8K | 681,239 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $10.3K | 4,673,247 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $9.6K | 4,278,819 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $9.1K | 293,900 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $8.2K | 79,200 | 0.0% |
| Cigna Corporation | COM | 125509109 | $7.1K | 42,600 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $7.1K | 130,900 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $6.8K | 1,948,554 | 0.0% |
| SOL GEL Technologies(SLGL) | SHS | M8694L103 | $6.7K | 647,700 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $6.6K | 658,900 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $6.3K | 86,786 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $6.3K | 2,078,799 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $6.2K | 477,607 | 0.0% |
| Pernix Therapeutics Hldgs in | DBCV 4.250% 4/0 | 71426VAK4 | $6.0K | 15,000,000 | 0.0% |
| Teligent Inc New | COM | 87960W104 | $5.7K | 1,690,794 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $5.2K | 166,500 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $4.7K | 374,233 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $4.3K | 300,000 | 0.0% |
| Natus Medical Inc del | COM | 639050103 | $3.8K | 113,526 | 0.0% |
| Progenics Pharmaceuticals inCall | COM | 743187106 | $3.7K | 500,000 | 0.0% |
| Varian MED SYS Inc(VAREUR) | COM | 92220P105 | $3.7K | 30,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $3.5K | 750,000 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $3.3K | 600,658 | 0.0% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $3.2K | 1,048,642 | 0.0% |
| Mediwound LTD | ORD SHS | M68830104 | $2.6K | 500,000 | 0.0% |
| Scynexis Inc | COM | 811292101 | $2.5K | 1,885,904 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.5K | 375,816 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $1.2K | 298,800 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $633 | 389,475 | 0.0% |
| Ovascience Inc | COM | 69014Q101 | $442 | 545,282 | 0.0% |